Clinical significance of PSMA, TERT and PDEF in malignant tumors of the prostate
J. Situ, H. Zhang, L. Lu, K. Li, C. Hu, D.-J. Wang Department of Urology, the Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou City, Guangdong Province, China.
The article “Clinical significance of PSMA, TERT and PDEF in malignant tumors of the prostate, by J. Situ, H. Zhang, L. Lu, K. Li, C. Hu, D.-J. Wang, published in Eur Rev Med Pharmacol Sci 2017; 21 (15): 3347-3352–PMID: 28829509” has been withdrawn from the authors due to inaccuracies in the research design.
The Publisher apologizes for any inconvenience this may cause.
Free PDF DownloadClinical significance of PSMA, TERT and PDEF in malignant tumors of the prostate
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
J. Situ, H. Zhang, L. Lu, K. Li, C. Hu, D.-J. Wang
Clinical significance of PSMA, TERT and PDEF in malignant tumors of the prostate
Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 20
Pages: 6158-6158
DOI: 10.26355/eurrev_202110_26971
Publication History
Published online: 27 Oct 2021